Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.4.3 (
phospholipase C
)
18,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Integral membrane protein
(
IMP
) antigens isolated from S. japonicum and S. mansoni adult worms using Triton X-114 phase partitioning were treated with phosphatidylinositol-specific
phospholipase C
(piPLC). Following piPLC treatment, only one
IMP
antigen of 58 kDa from each species was released from the hydrophobic fraction and remained soluble in the absence of detergent. An additional 23 kDa antigen was identified following piPLC treatment of S. japonicum
IMP
's. This molecule has been previously characterized as an important species specific immunodiagnostic antigen. Alkaline phosphatase activity was observed in both the detergent and aqueous phases following treatment with piPLC but only in the hydrophobic fraction of the controls. These data suggest that only a small number of
IMP
antigens from both S. japonicum and S. mansoni adult worms possess glycosyl-phosphatidylinositol (GPI) lipid membrane anchors in a form which can be hydrolysed by a heterologous piPLC.
...
PMID:A preliminary examination of the major integral membrane protein antigens of Schistosoma japonicum and Schistosoma mansoni adult worms for glycosyl-phosphatidylinositol membrane anchors. 183 41